Pharmacokinetics of Piperacillin, Given as Continuous Infusion to Patients With Cystic Fibrosis

Update Il y a 4 ans
Reference: NCT01983787

Woman and Man

  • | Country :
  • Denmark
  • | organs :
  • -
  • | Specialty :
  • -

Extract

At the Department of Infectious Diseases, Aarhus University Hospital, continuous infusion with piperacillin/tazobactam for a period of 2 weeks, has been used for several years in patients with cystic fibrosis, suffering from acute pulmonary exacerbations (APE). It is an outpatient treatment. To assess the efficacy and quality of the treatment, a blood test every 3rd day is taken to determine the concentration of Piperacillin in blood-plasma.


Inclusion criteria

  • Cystic fibrosis

Links